The NYC Hep C Task Force & Hep B Coalition created a workgroup in 2013 to address hepatitis in the Caribbean communities of NYC.
Goals
Current Activities
Contact
Last Updated on January 25, 2020 by HepFree NYC
Related Articles
-
2014 NYC Health Dept Hep B & C Annual Report
The Health Department today released a new report detailing the city’s hepatitis B and C surveillance, research, and programmatic activities in 2014.
-
Patient Survey | Hep C Diagnosis Uncertainty in Baby Boomers
“Have you been diagnosed with Hepatitis C? Are you a Baby Boomer – born between 1945 – 1965, and uncertain about your diagnosis? Do you write and understand English?”
-
PCSI Data Brief | “Geographic Co-occurrence of HIV/AIDS, Viral Hepatitis, STDs&Tuberculosis in NYC”
See report displaying disease co-occurrence of HIV/AIDS, Hepatitis, STDs and Tuberculosis in NYC neighborhoods.
-
NY Governor Announces First-In-Nation Task Force To Eliminate Hepatitis C
Governor Andrew M. Cuomo today announced the nation's first strategy to eliminate hepatitis C, including the establishment of a Hepatitis C Elimination Task Force that will advise the state as it implements its plan going forward.
-
Presentation | Hep C Prior Authorization Tips from the Pros
his presentation includes tips from providers experienced with advocating successfully for hepatitis C medication coverage for their patients.
-
NYS Governor Cuomo signs bill into law requiring health care providers to offer Hep C testing
Governor Andrew M. Cuomo today signed a new law that will better protect baby boomer New Yorkers from Hepatitis C by requiring hospitals and health service providers to offer testing for the virus to all patients born between 1945 and 1965
-
Ask Congress to #FundHep
Join the #FundHep social media campaign in an effort to advocate for more Federal funds for hepatitis in FY2017!
-
O’Neill Institute Launches Hep C Policy Project
The O’Neill Institute for National and Global Health Law, a part of the Georgetown Law, announces the launch of the Hepatitis Policy Project (HPP) to focus on issues and barriers of access to effective treatments for hepatitis C.
